A pivotal role (top over-expressed gene) was assigned to FGFR4 (fibroblast growth factor receptor 4), a well-known player in ovarian and BC tumorigenesis whose over-expression, especially in BC, characterizes the HER2-E intrinsic subtype. This evidence concerns the gene ERBB2 and breast cancer.